Alterations of Hrd1 expression in various encephalic regional neurons in 6-OHDA model of Parkinson's disease

Neuroscience Letters

Volumn 474, Issue 2, 2010, Pages 63-68

  Mei, Jiaming ^a,b   Niu, Chaoshi ^a,b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Anhui Provincial Stereotactic Neurosurgical Institute   (China)

Author keywords

6 OHDA; Endoplasmic reticulum; Hrd1; Parkinson's disease

Indexed keywords

UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE HRD1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN NERVE CELL; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; ENDOPLASMIC RETICULUM STRESS; ENZYME INDUCTION; FRONTAL LOBE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; RAT; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIPARKINSON AGENTS; APOMORPHINE; BRAIN; DISEASE MODELS, ANIMAL; MALE; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; SYMPATHOLYTICS; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

EID: 77951208862     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.02.033     Document Type: Article

References (21)

1. About-Sleinman P.M., Muqit M.M., Wood N.W. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat. Rev. Neurosci. 2006, 7:207-219.
2. Ahner A., Brodsky J.L. Checkpoints in ER-associated degradation: excuse me, which way to the proteasome?. Trends Cell Biol. 2004, 14:474-479.
3. Bao X.M., Shu S.Y. The Stereotaxic Atlas of the Rat Brain 1991, People's Medical Publishing House, China.
4. Blandini F., Nappi G., Tassorelli C., Martignoni E. Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog. Neurobiol. 2000, 62:63-88.
5. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
6. Deak P.M., Wolf D.H. Membrane topology and function of Der3/Hrd1p as a ubiquitin-protein ligase (E3) involved in endoplasmic reticulum degradation. J. Biol. Chem. 2001, 276:10663-10669.
7. Deumens R., Blokland A., Prickaerts J. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 2002, 175:303-317.
8. Gelman M.S., Kannegaard E.S., Kopito R.R. A principal role for the proteasome in endoplasmic reticulum-associated degradation of misfolded intracellular cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 2002, 277:11709-11714.
9. Hamani C., Saint-Cyr J.A., Fraser J., Kaplitt M., Lozano A.M. The subthalamic nucleus in the context of movement disorders. Brain 2004, 127:4-20.
10. Hegde A.N. ubiquitin-proteasome-mediated local protein degradation and synaptic plasticity. Prog. Neurobiol. 2004, 73:311-357.
11. Hou H.L., Shen Y.X., Zhu H.Y., Sun H., Yan X.B., Fang H., Zhou J.N. Alterations of hHrd1 expression are related to hyperphosphorylated tau in the hippocampus in Alzheimer's disease. J. Neurosci. Res. 2006, 84:1862-1870.
12. Kaneko M., Nomura Y. ER signaling in unfolded protein response. Life Sci. 2003, 74:199-205.
13. Kaneko M., Ishiguro M., Niinuma Y., Uesugi M., Nomura Y. Human HRD1 protects against ER stress-induced apoptosis through ER-associated degradation. FEBS Lett. 2002, 532:147-152.
14. Kikkert M., Doolman R., Dai M., Avner R., Hassink G., van Voorden S., Thanedar S., Roitelman J., Chau V., Wiertz E. Human HRD1 is an E3 ubiquitin ligase involved in degradation of proteins from the endoplasmic reticulum. J. Biol. Chem. 2004, 279:3525-3534.
15. Kostova Z., Wolf D.H. For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin-proteasome connection. EMBO J. 2003, 22:2309-2317.
16. Lodish H.F., Kong N. Perturbation of cellular calcium blocks exit of secretory proteins from the rough endoplasmic reticulum. J. Biol. Chem. 1990, 265:10893-10899.
17. McNaught K.S., Belizaire R., Isacson O., Jenner P., Olanow C.W. Altered proteasomal function in sporadic Parkinson's disease. Exp. Neurol. 2003, 179:38-46.
18. Ryu E.J., Harding H.P., Angelastro J.M., Vitolo O.V., Ron D., Greene L.A. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J. Neurosci. 2002, 22:10690-10698.
19. Schober A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res. 2004, 318:215-224.
20. Strauss U., Zhou F.W., Henning J., Battefeld A., Wree A., Köhling R., Haas S.J., Benecke R., Rolfs A., Gimsa U. Increasing extracellular potassium results in subthalamic neuron activity resembling that seen in a 6-hydroxydopamine lesion. J. Neurophysiol. 2008, 99:2902-2915.
21. Yang H., Zhong X., Ballar P., Luo S., Shen Y., Rubinsztein D.C., Monteiro M.J., Fang S. Ubiquitin ligase Hrd1 enhances the degradation and suppresses the toxicity of polyglutamine-expanded huntingtin. Exp. Cell Res. 2007, 313:538-550.